跨祖先非HLA遗传结构将胰岛素分泌与抵抗联系至1型糖尿病
本研究对26,198例1型糖尿病病例和36,733例对照进行多祖先全基因组关联研究荟萃分析,识别出69个非HLA风险区域,其中3个为新信号。超过三分之一的变异与胰岛素分泌或抵抗指标相关,整合表观遗传和功能分析提示ADCY7为16q12.1位点可能因果基因,支持非HLA遗传结构连接1型糖尿病易感性与胰岛素分泌受损和抵抗。
要点
- 多祖先GWAS荟萃分析发现69个非HLA 1型糖尿病风险区域,含3个新信号。
- 26/69个变异与胰岛素分泌或抵抗指数相关,富集于相关通路。
- ADCY7被鉴定为16q12.1新位点可能因果基因,双向调控胰岛素分泌和凋亡。
核心结论
- 非HLA遗传结构可能连接1型糖尿病易感性与胰岛素分泌受损及胰岛素抵抗,为其汇聚致病机制提供初步遗传证据。
研究设计与样本
- 多祖先1型糖尿病全基因组关联研究荟萃分析,纳入26,198例病例和36,733例对照。
主要发现
- 观察到69个非HLA 1型糖尿病风险区域,包括三个新全基因组显著信号:AHI1基因rs2179781(OR 1.074,p=1.19×10-8)、TRAF1附近rs10117059(OR 1.074,p=3.95×10-8)和ADCY7附近rs7184802(OR 1.089,p=4.12×10-8)。
- 超过三分之一(26/69)的变异与胰岛素分泌或抵抗指数相关。
- 贝叶斯精细定位整合三种注释策略优先选出136个推定功能变异。
- 整合Roadmap表观基因组数据揭示这些变异在关键代谢组织(胰岛、肝、骨骼肌和脂肪)中具有升高调控潜力。
- 计算映射注释涉及447个候选基因,富集于胰岛素分泌和抵抗相关通路(p=5.41×10-4和2.10×10-5),HLA风险基因无此模式。
关键数值与推荐
- 新信号rs2179781(AHI1)OR 1.074,p=1.19×10-8;rs10117059(TRAF1附近)OR 1.074,p=3.95×10-8;rs7184802(ADCY7附近)OR 1.089,p=4.12×10-8。
- 26/69个非HLA变异与胰岛素分泌或抵抗指数相关。
- 候选基因富集于胰岛素分泌通路p=5.41×10-4,胰岛素抵抗通路p=2.10×10-5。
临床怎么用
- 提示非HLA遗传变异可能通过影响胰岛素分泌和抵抗参与1型糖尿病 pathogenesis,为风险分层和机制研究提供线索。
- ADCY7作为新位点可能因果基因,在β细胞和脂肪细胞中调控胰岛素分泌、凋亡和脂生成,值得进一步转化研究。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Type 1 diabetes is an autoimmune disease with a strong genetic component. Nevertheless, the genetic underpinnings linking type 1 diabetes susceptibility to both insulin secretion and insulin resistance across diverse ancestries have yet to be fully characterised. METHODS: We performed a multi-ancestry type 1 diabetes genome-wide association study meta-analysis comprising 26,198 cases and 36,733 control individuals to identify risk regions across diverse ancestral populations. We further evaluated their associations with clinical traits, integrated epigenetic profiles, mapped candidate genes to define tissue and cell type specificity, and conducted pathway enrichment analyses to elucidate the genetic links between type 1 diabetes and both insulin secretion and insulin resistance. RESULTS: We observed 69 non-HLA regions for type 1 diabetes risk, including three novel genome-wide association study signals: rs2179781 in AHI1 (OR 1.074, p=1.19×10-8), rs10117059 near TRAF1 (OR 1.074, p=3.95×10-8) and rs7184802 near ADCY7 (OR 1.089, p=4.12×10-8). Notably, over one-third (26/69) of these variants were associated with insulin secretion or resistance indices. Using Bayesian fine-mapping integrated with three complementary annotation strategies, we prioritised 136 putative functional variants. Integrative analysis leveraging Roadmap Epigenomics data revealed that these variants exhibited elevated regulatory potential, as evidenced by DNase I hypersensitivity, characteristic H3 histone modifications and active chromatin states in key metabolic tissues (pancreatic islets, liver, skeletal muscle and adipose). Computational mapping and annotation of these variants implicated 447 candidate genes, which showed metabolic tissue-specific expression, and were enriched in pathways related to insulin secretion and resistance (p=5.41×10-4 and 2.10×10-5, respectively), a pattern not evident for HLA risk genes. Subsequent functional characterisation identified ADCY7, regulated by functional variant rs1872691, as the probable causal gene at the novel 16q12.1 locus. In pancreatic beta cells, proinflammatory cytokines downregulated Adcy7 expression and Adcy7 perturbation bidirectionally modulated both insulin secretion and cytokine-induced apoptosis. Conversely, Adcy7 knockdown in adipocytes augmented lipogenesis and enhanced insulin sensitivity. CONCLUSIONS/INTERPRETATION: Our findings support the existence of a shared non-HLA genetic architecture that may link type 1 diabetes susceptibility to both impaired insulin secretion and insulin resistance, providing preliminary genetic evidence for their convergent pathogenic mechanisms.
引用
- Fu Q, Wang K, Shen M, et al. Shared non-HLA genetic architecture across diverse ancestries links insulin secretion and resistance to type 1 diabetes. Diabetologia. 2026. PMID: 42771182. doi:10.1007/s00125-026-06865-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。